These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 38943731)
1. Current understanding of free fatty acids and their receptors in colorectal cancer treatment. Binienda A; Fichna J Nutr Res; 2024 Jul; 127():133-143. PubMed ID: 38943731 [TBL] [Abstract][Full Text] [Related]
2. Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer. Bartoszek A; Fichna J; Tarasiuk A; Binienda A; Fabisiak A; Krajewska JB; Mosińska P; Niewinna K; Salaga M Curr Drug Targets; 2020; 21(14):1397-1404. PubMed ID: 31721710 [TBL] [Abstract][Full Text] [Related]
3. Free fatty acid receptor (FFAR) agonists inhibit proliferation of human ovarian cancer cells. Hopkins MM; Meier KE Prostaglandins Leukot Essent Fatty Acids; 2017 Jul; 122():24-29. PubMed ID: 28735625 [TBL] [Abstract][Full Text] [Related]
4. Free Fatty Acid Receptors and Cancer: From Nutrition to Pharmacology. Hopkins MM; Meier KE Handb Exp Pharmacol; 2017; 236():233-251. PubMed ID: 27757756 [TBL] [Abstract][Full Text] [Related]
5. The Anticancer Role of Omega-3 Polyunsaturated Fatty Acids was Closely Associated with the Increase in Genomic DNA Hydroxymethylation. Huang Q; Mo M; Zhong Y; Yang Q; Zhang J; Ye X; Zhang L; Cai C Anticancer Agents Med Chem; 2019; 19(3):330-336. PubMed ID: 30338745 [TBL] [Abstract][Full Text] [Related]
6. G-protein-coupled receptors mediate ω-3 PUFAs-inhibited colorectal cancer by activating the Hippo pathway. Zhang K; Hu Z; Qi H; Shi Z; Chang Y; Yao Q; Cui H; Zheng L; Han Y; Han X; Zhang Z; Chen T; Hong W Oncotarget; 2016 Sep; 7(36):58315-58330. PubMed ID: 27506947 [TBL] [Abstract][Full Text] [Related]
7. Gene expression of free fatty acids-sensing G protein-coupled receptors in beef cattle. Durand G; Charrier P; Bes S; Bernard L; Lamothe V; Gruffat D; Bonnet M J Anim Sci; 2024 Jan; 102():. PubMed ID: 38659415 [TBL] [Abstract][Full Text] [Related]
8. Inhibitors of Fatty Acid Synthesis and Oxidation as Potential Anticancer Agents in Colorectal Cancer Treatment. Mozolewska P; Duzowska K; Pakiet A; Mika A; ŚledziŃski T Anticancer Res; 2020 Sep; 40(9):4843-4856. PubMed ID: 32878772 [TBL] [Abstract][Full Text] [Related]
9. Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Cockbain AJ; Toogood GJ; Hull MA Gut; 2012 Jan; 61(1):135-49. PubMed ID: 21490374 [TBL] [Abstract][Full Text] [Related]
10. Free Fatty Acid Receptors in Health and Disease. Kimura I; Ichimura A; Ohue-Kitano R; Igarashi M Physiol Rev; 2020 Jan; 100(1):171-210. PubMed ID: 31487233 [TBL] [Abstract][Full Text] [Related]
11. Free Fatty Acid Receptors (FFARs) in Adipose: Physiological Role and Therapeutic Outlook. Al Mahri S; Malik SS; Al Ibrahim M; Haji E; Dairi G; Mohammad S Cells; 2022 Feb; 11(4):. PubMed ID: 35203397 [TBL] [Abstract][Full Text] [Related]
12. Biochemical and Metabolical Pathways Associated with Microbiota-Derived Butyrate in Colorectal Cancer and Omega-3 Fatty Acids Implications: A Narrative Review. Gheorghe AS; Negru ȘM; Preda M; Mihăilă RI; Komporaly IA; Dumitrescu EA; Lungulescu CV; Kajanto LA; Georgescu B; Radu EA; Stănculeanu DL Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334808 [TBL] [Abstract][Full Text] [Related]
13. Immune regulation of poly unsaturated fatty acids and free fatty acid receptor 4. Duah M; Zhang K; Liang Y; Ayarick VA; Xu K; Pan B J Nutr Biochem; 2023 Feb; 112():109222. PubMed ID: 36402250 [TBL] [Abstract][Full Text] [Related]
14. Molecular Targets of Omega-3 Fatty Acids for Cancer Therapy. Devi KP; Rajavel T; Russo GL; Daglia M; Nabavi SF; Nabavi SM Anticancer Agents Med Chem; 2015; 15(7):888-95. PubMed ID: 25909897 [TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells. Liu Z; Hopkins MM; Zhang Z; Quisenberry CB; Fix LC; Galvan BM; Meier KE J Pharmacol Exp Ther; 2015 Feb; 352(2):380-94. PubMed ID: 25491146 [TBL] [Abstract][Full Text] [Related]
16. Characterization of Butyrate-Resistant Colorectal Cancer Cell Lines and the Cytotoxicity of Anticancer Drugs against These Cells. Nittayaboon K; Leetanaporn K; Sangkhathat S; Roytrakul S; Navakanitworakul R Biomed Res Int; 2022; 2022():6565300. PubMed ID: 35909471 [TBL] [Abstract][Full Text] [Related]
17. The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility. Hawcroft G; Volpato M; Marston G; Ingram N; Perry SL; Cockbain AJ; Race AD; Munarini A; Belluzzi A; Loadman PM; Coletta PL; Hull MA Br J Pharmacol; 2012 Jul; 166(5):1724-37. PubMed ID: 22300262 [TBL] [Abstract][Full Text] [Related]
18. Modulating Pluripotency Network Genes with Omega-3 DHA is followed by Caspase- 3 Activation and Apoptosis in DNA Mismatch Repair-Deficient/KRAS-Mutant Colorectal Cancer Stem-Like Cells. Mahmoudi N; Delirezh N; Sam MR Anticancer Agents Med Chem; 2020; 20(10):1221-1232. PubMed ID: 32116204 [TBL] [Abstract][Full Text] [Related]
19. Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancer. Volpato M; Hull MA Cancer Metastasis Rev; 2018 Sep; 37(2-3):545-555. PubMed ID: 29971573 [TBL] [Abstract][Full Text] [Related]
20. CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression. Hsu HC; Liu YS; Tseng KC; Yang TS; Yeh CY; You JF; Hung HY; Chen SJ; Chen HC J Cancer Res Clin Oncol; 2015 Jan; 141(1):11-21. PubMed ID: 25060070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]